Healthcare provider profile · identity verified

Stephen D Turner, MD

Internal Medicine · FISHERSVILLE, VA · NPI 1043424039

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	215	39
Trazodone Hcl	Trazodone Hcl	215	43
Amlodipine Besylate	Amlodipine Besylate	214	39
Gabapentin	Gabapentin	208	46
Atorvastatin Calcium	Atorvastatin Calcium	199	49
Metoprolol Succinate	Metoprolol Succinate	184	41
Lisinopril	Lisinopril	169	35
Pantoprazole Sodium	Pantoprazole Sodium	166	33
Rosuvastatin Calcium	Rosuvastatin Calcium	157	32
Eliquis	Apixaban	148	28
Losartan Potassium	Losartan Potassium	124	29
Quetiapine Fumarate	Quetiapine Fumarate	118	20
Mirtazapine	Mirtazapine	115	23
Tamsulosin Hcl	Tamsulosin Hcl	115	27
Furosemide	Furosemide	111	30
Duloxetine Hcl	Duloxetine Hcl	105	18
Famotidine	Famotidine	105	18
Metformin Hcl	Metformin Hcl	104	18
Omeprazole	Omeprazole	97	28
Carvedilol	Carvedilol	96	21
Alendronate Sodium	Alendronate Sodium	83	12
Divalproex Sodium	Divalproex Sodium	78	suppressed
Spironolactone	Spironolactone	78	13
Donepezil Hcl	Donepezil Hcl	75	13
Escitalopram Oxalate	Escitalopram Oxalate	74	20
Allopurinol	Allopurinol	64	14
Divalproex Sodium Er	Divalproex Sodium	64	suppressed
Fluticasone Propionate	Fluticasone Propionate	62	24
Albuterol Sulfate Hfa	Albuterol Sulfate	61	34
Buspirone Hcl	Buspirone Hcl	59	11
Clopidogrel	Clopidogrel Bisulfate	59	suppressed
Latanoprost	Latanoprost	59	11
Montelukast Sodium	Montelukast Sodium	59	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	56	14
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	55	suppressed
Sertraline Hcl	Sertraline Hcl	55	13
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	51	suppressed
Memantine Hcl	Memantine Hcl	51	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Januvia	Sitagliptin Phosphate	49	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	suppressed
Simvastatin	Simvastatin	48	suppressed
Jardiance	Empagliflozin	47	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	46	suppressed
Ozempic	Semaglutide	45	suppressed
Levetiracetam	Levetiracetam	44	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Potassium Chloride	Potassium Chloride	41	14
Pregabalin	Pregabalin	41	11
Lithium Carbonate	Lithium Carbonate	39	suppressed
Cephalexin	Cephalexin	38	22
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Dapagliflozin	Dapagliflozin Propanediol	36	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	35	suppressed
Finasteride	Finasteride	34	suppressed
Lamotrigine	Lamotrigine	34	suppressed
Mirabegron Er	Mirabegron	34	suppressed
Topiramate	Topiramate	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Prednisone	Prednisone	33	20
Xarelto	Rivaroxaban	33	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	14
Olanzapine	Olanzapine	28	suppressed
Benztropine Mesylate	Benztropine Mesylate	27	suppressed
Linzess	Linaclotide	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Risperidone	Risperidone	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	12
Ondansetron Odt	Ondansetron	24	17
Vraylar	Cariprazine Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Colchicine	Colchicine	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Rexulti	Brexpiprazole	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Gemtesa	Vibegron	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Buprenorphine	Buprenorphine	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Nystatin	Nystatin	16	13
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Tiotropium Bromide	Tiotropium Bromide	16	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Atenolol	Atenolol	14	suppressed
Azathioprine	Azathioprine	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Silodosin	Silodosin	13	suppressed
Sulfasalazine Dr	Sulfasalazine	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Methimazole	Methimazole	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Primidone	Primidone	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error